Cargando…
Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine
Hepatocellular carcinoma rarely occurs in patients without underlying cirrhosis or liver disease. While inflammatory bowel disease has been linked to certain forms of liver disease, hepatocellular carcinoma is exceedingly rare in these patients. We report the twelfth case of hepatocellular carcinoma...
Autores principales: | Heron, Valérie, Fortinsky, Kyle Joshua, Spiegle, Gillian, Hilzenrat, Nir, Szilagyi, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929375/ https://www.ncbi.nlm.nih.gov/pubmed/27403102 http://dx.doi.org/10.1159/000444012 |
Ejemplares similares
-
Metastatic Hepatocellular Carcinoma in a Patient with Crohn's Disease Treated with Azathioprine and Infliximab: A Case Report and Literature Review
por: Fortinsky, Kyle J., et al.
Publicado: (2014) -
Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?
por: Botros, Youssef, et al.
Publicado: (2015) -
Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease
por: Connors, William, et al.
Publicado: (2014) -
Recalcitrant plantar warts during azathioprine therapy for Crohn’s disease
por: Timmer, Margriet R., et al.
Publicado: (2013) -
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease
por: Roselli, Jenny, et al.
Publicado: (2020)